FindTrial
Sign In

The role of phospholipid transfer protein in inflammatory response and prognostic evaluation for sepsis patients

The role of phospholipid transfer protein in inflammatory response and prognostic evaluation for sepsis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098114
Enrollment
Unknown
Registered
2025-03-03
Start date
2024-05-10
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

shock group:NA
sepsis group:NA
Septic shock group:NA
Non sepsis and shock group:NA

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old; 2. Receive treatment in the ICU; 3. Diagnosis of sepsis and septic shock in accordance with sepsis-3 criteria;

Exclusion criteria

Exclusion criteria: 1. Return to ICU within 48 hours; 2. Accept other clinical studies; 3. Use of non steroidal anti-inflammatory drugs for treatment prior to inclusion or during the course of this study; 4. Pregnant women;

Design outcomes

Primary

MeasureTime frame
Phospholipid transfer protein activity;—

Secondary

MeasureTime frame
TNF-a;IL-1ß;IL-6;IL-10;—

Countries

China

Contacts

Public ContactDawei Wang

Shandong Provincial Hospital

wdw_syr@163.com+86 531 68777120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026